A1 Refereed original research article in a scientific journal
Male Reproductive Disorders, Diseases, and Costs of Exposure to Endocrine-Disrupting Chemicals in the European Union
Authors: Hauser R, Skakkebaek NE, Hass U, Toppari J, Juul A, Andersson AM, Kortenkamp A, Heindel JJ, Trasande L
Publisher: ENDOCRINE SOC
Publication year: 2015
Journal: Journal of Clinical Endocrinology and Metabolism
Journal name in source: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Journal acronym: J CLIN ENDOCR METAB
Volume: 100
Issue: 4
First page : 1267
Last page: 1277
Number of pages: 11
ISSN: 0021-972X
eISSN: 1945-7197
DOI: https://doi.org/10.1210/jc.2014-4325
Conclusions: EDCs may contribute substantially to male reproductive disorders and diseases, with nearly (sic)15 billion annual associated costs in the EU. These estimates represent only a few EDCs for which there were sufficient epidemiological studies and those with the highest probability of causation. These public health costs should be considered as the EU contemplates regulatory action on EDCs.